US, EU filings for Eisai’s lenvatinib in liver cancer
admin 26th July 2017 Uncategorised 0Eisai has filed its anticancer drug lenvatinib for liver cancer on both sides of the Atlantic as it seeks to expand the drug’s list of approved uses.
More: US, EU filings for Eisai’s lenvatinib in liver cancer
Source: News